Endocrine Abstracts

Introduction: With the advent of specific gene targeted therapies for advanced thyroid cancers it has become important that molecular genetic testing is requested to identify patients suitable for these treatments, for example with BRAF, RET or NTRK inhibitors. We investigated the proportion of patients with advanced thyroid cancer in a specialist thyroid cancer clinic who had undergone appropriate testing.Participants and Method...